Skip to main content
. 2012 Jul;1(1):23–34. doi: 10.3978/j.issn.2224-4336.2012.03.03

Figure 3.

Figure 3

Each infant was assessed for the number of GER events/day (visible emesis and/or rumination). After one-month post-study medication, use of PP did not decrease the amount of GER episodes compared to their pre-study value. Treatment with either OB or OP decreased the number of GER episodes per day compared to their study entry, though this was statistically significant only for the OB group (P=0.028). After an open label period of bethanacol and omeprazole, the PP group demonstrated a decrease in GER episodes similar to OB though it did not reach statistical significance (P=0.06) (B).